MedPath

The international, multicentre collaboration on portal vein obstruction revascularisation therapy after liver transplantation in paediatric: evaluation of standard of care

Conditions
Portal vein obstruction
Registration Number
NL-OMON20671
Lead Sponsor
niversity Medical Centre Groningen (UMCG)
Brief Summary

one

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Not specified
Target Recruitment
400
Inclusion Criteria

1. Treated for PVO (PVAS or PVT) after liver transplantation (all interventions are included and conservative treatment as well)
2. Age at intervention <18 years
3. Intervention in period 01-01-2001 and 01-01-2021

Exclusion Criteria

None

Study & Design

Study Type
Observational non invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Primary and secondary patency after PVO intervention, and patient and graft survival after PVO intervention
Secondary Outcome Measures
NameTimeMethod
Prevalence of PVO after liver transplantation, clinical and imaging characteristics of patients before treatment, technical success numbers of all treatment strategies, occurrence of complications after treatment and post-interventional management (especially anticoagulant/antiplatelet prophylaxis).
© Copyright 2025. All Rights Reserved by MedPath